Viatris (VTRS) EBT Margin Growth (3y) (2022 - 2026)
Viatris (VTRS) EBT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | -4,603.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,020.00 |
| Mar 31, 2026 | -1,570.00 |
| Dec 31, 2025 | -4,672.00 |
| Sep 30, 2025 | -1,072.00 |
| Jun 30, 2025 | -1,557.00 |
| Mar 31, 2025 | -10,779.00 |
| Dec 31, 2024 | -1,049.00 |
| Sep 30, 2024 | -201.00 |
| Jun 30, 2024 | -555.00 |
| Mar 31, 2024 | 1,561.00 |
| Dec 31, 2023 | 546.00 |
| Mar 31, 2023 | 747.00 |
| Dec 31, 2022 | 3,619.00 |